tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Grundinformationen
- CAS
571188-59-5- Standard-SMILES
CC(C)(C)OC(=O)N1CCN(c2ccc(N)nc2)CC1- InChIKey
RMULRXHUNOVPEI-UHFFFAOYSA-N- Summenformel
- C14H22N4O2
- Durchschnittliche Molmasse
- 278,35 g/mol
- Monoisotopische Masse
- 278,17427596
Namen und Bezeichner
- Bevorzugter Name
- tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
- IUPAC
- tert-butyl 4-(6-amino-3-pyridinyl)piperazine-1-carboxylate
- Englischer Name
- tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
- Summenformel
- C14H22N4O2
- Molmasse
- 278.35
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
571188-59-5- PubChem CID
- 11737525
- DTXSID
DTXSID10471464- ChEMBL
CHEMBL4534399- UNII
- 6Y3BU8W3TC
- EC Number
- 695-268-4
- Nikkaji
- J3.757.220I
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1,3
- Polarare Oberfläche (TPSA)
- 71,7 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 335
Physikochemische Eigenschaften
- Schmelzpunkt
- 130 · 130-132℃
- Siedepunkt
- 454.1 · 454.1±45.0 °C(Predicted)
- Dichte
- 1.182 · 1.182
- Dampfdruck
- 0 · 0-0Pa at 20-25℃
- storage temp.
- Keep in dark place,Inert atmosphere,Room temperature
- Löslichkeit
- DMSO (Slightly), Methanol (Very Slightly)
- Aggregatzustand
- Solid
- pka
- 7.36 · 7.36±0.26(Predicted)
- Farbe
- Dark Yellow
- InChI
- InChI=1S/C14H22N4O2/c1-14(2,3)20-13(19)18-8-6-17(7-9-18)11-4-5-12(15)16-10-11/h4-5,10H,6-9H2,1-3H3,(H2,15,16)
- InChIKey
- RMULRXHUNOVPEI-UHFFFAOYSA-N
- SMILES
- N1(C(OC(C)(C)C)=O)CCN(C2=CC=C(N)N=C2)CC1
- LogP
- 1.6 · 1.6-1.8 at 35℃ and pH7-9
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H301 (11.1%): Toxic if swallowed [Danger Acute toxicity, oral];H302 (55.6%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (44.4%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (22.2%): May cause an allergic skin reaction [Warning Sensitization, Skin];H318 (22.2%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (33.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (33.3%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P272, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 9 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Regulatory Information
Status: Active Update: 24-07-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/26707;Status: Active Update: 22-09-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/18360;Status: Active Update: 16-07-2013 https://echa.europa.eu/registration-dossier/-/registered-dossier/6898
Regulatorische Informationen
Regulatory Information
Status: Active Update: 24-07-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/26707;Status: Active Update: 22-09-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/18360;Status: Active Update: 16-07-2013 https://echa.europa.eu/registration-dossier/-/registered-dossier/6898
Sicherheitsdaten
- hs_code
- 2933599590
Chemie und Industrie
Anwendungen
BeschreibungTert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate is a pharmaceutical intermediate compound that can be used to synthesize the targeted cancer drug Ribociclib for the treatment of ER-positive and HER2-negative breast cancer.
Verwenden4-(6-Amino-3-pyridyl)-1-Boc-piperazine (tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate) is used as an organic chemical synthesis intermediate.
Darstellung
synthetische4- (6-Nitro-pyridin-3-yl)-piperazine-1 -carboxylic acid ie f-butyl ester and Pd/C in ethanol is stirred with an H2 balloon for 3 h. The product tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate is obtained through purification.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…